BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mishra J, Stubbs M, Kuang L, Vara N, Kumar P, Kumar N, Subramanian VS. Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering. Mediators of Inflammation 2022;2022:1-15. [DOI: 10.1155/2022/9621668] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Núñez-sánchez MA, Melgar S, O’donoghue K, Martínez-sánchez MA, Fernández-ruiz VE, Ferrer-gómez M, Ruiz-alcaraz AJ, Ramos-molina B. Crohn’s Disease, Host–Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches. IJMS 2022;23:8361. [DOI: 10.3390/ijms23158361] [Reference Citation Analysis]
2 Xu L, Liu B, Huang L, Li Z, Cheng Y, Tian Y, Pan G, Li H, Xu Y, Wu W, Cui Z, Xie L. Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model. Microbiol Spectr 2022;:e0065722. [PMID: 35730951 DOI: 10.1128/spectrum.00657-22] [Reference Citation Analysis]
3 Karthika C, Sureshkumar R, Zehravi M, Akter R, Ali F, Ramproshad S, Mondal B, Tagde P, Ahmed Z, Khan FS, Rahman MH, Cavalu S. Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein. Life (Basel) 2022;12:897. [PMID: 35743927 DOI: 10.3390/life12060897] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 De Conno B, Pesce M, Chiurazzi M, Andreozzi M, Rurgo S, Corpetti C, Seguella L, Del Re A, Palenca I, Esposito G, Sarnelli G. Nutraceuticals and Diet Supplements in Crohn's Disease: A General Overview of the Most Promising Approaches in the Clinic. Foods 2022;11:1044. [PMID: 35407131 DOI: 10.3390/foods11071044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]